Recent studies have shown that, during cell death, the protein Omi is released from the mitochondrial intermembrane space into the cytosol, where it augments caspase-dependent apoptosis by blocking inhibitors and may induce caspase-independent cell death via its serine protease activity. Each of the groups that identified Omi [3-6] used an affinity chromatography strategy to purify XIAP (or XIAP-BIR3) binding proteins; in each case, the approach yielded both Smac/DIABLO and the novel protein Omi. The 36 kDa Omi is derived from a 50 kDa precursor which has three distinct domains: an aminoterminal mitochondrial translocation sequence (MTS), a trypsin-like protease domain, and a carboxyterminal PDZ domain (Figure 2) . The Omi precursor resides in the mitochondria, where it undergoes autocatalytic removal of the MTS to generate the mature 36 kDa form. Strikingly, sequence analysis of mature Omi revealed a putative amino-terminal IAP-binding motif (AVPS) similar to that found in Smac/diabolo, caspase-9 and the Drosophila proteins Reaper, Hid and Grim (Figure 2) [9-14] . Subsequent studies confirmed that this motif allows Omi to bind IAPs and suppress their caspase-inhibitory activity in cell-free apoptosis assays. Moreover, apoptotic stimuli were found to induce release of Omi into the cytosol, where it binds IAPs and appears to enhance caspase-dependent apoptosis (Figure 1, green pathway) . Deletion or mutation of Omi's AVPS motif completely prevented its interaction with IAPs, but failed to completely abolish its death inducing activity, suggesting that Omi acts as more than an IAP-binding protein.
Apoptosis is a conserved cellular suicide program that eradicates excess or potentially dangerous cells; its many important physiological functions include terminating immune responses and eliminating virally infected or cancerous cells [1] . The induction of apoptosis relies critically on the mitochondria, as these organelles release apoptogenic factors that activate caspases, a family of proteinases that kill the cell via proteolysis of key substrates [2] . Recent studies [3] [4] [5] [6] have shed new light on this process and shown that, during cell death, mitochondria release a protein known as Omi into the cytosol. In the cytosol, Omi augments caspase activation by blocking endogenous caspase inhibitors and may also activate caspaseindependent death pathways through its serine protease activity.
Two main pathways have been defined that initiate caspase activation ( . Subsequent studies confirmed that this motif allows Omi to bind IAPs and suppress their caspase-inhibitory activity in cell-free apoptosis assays. Moreover, apoptotic stimuli were found to induce release of Omi into the cytosol, where it binds IAPs and appears to enhance caspase-dependent apoptosis (Figure 1, green pathway) . Deletion or mutation of Omi's AVPS motif completely prevented its interaction with IAPs, but failed to completely abolish its death inducing activity, suggesting that Omi acts as more than an IAP-binding protein. 
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